查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1477511

虫媒病毒测试市场-全球产业规模、份额、趋势、机会和预测，按测试类型（RT-PCR 测试、ELISA 测试）、最终用户（医院、诊断中心）、地区和竞争细分，2019-2029F

Arbovirus Testing Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (RT-PCR Test, ELISA-Test), By End User (Hospitals, Diagnostic Centers), By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2023 年全球虫媒病毒检测市场价值为 11.5 亿美元，预计在预测期内将强劲增长，到 2029 年复合年增长率为 5.72%。虫媒病毒主要透过蚊子和蜱虫等昆虫传播，引起了越来越多的关注，因为它们可能导致严重且往往致命的人类疾病。随着医疗保健系统旨在增强其诊断能力，以有效识别和管理这些病毒感染，该市场正在经历显着成长。市场扩张的主要驱动因素包括虫媒病毒疾病发病率的上升、医疗保健专业人员意识的提高以及对精确和及时诊断的迫切需求。世界各地的政府和医疗机构正在投资研发，以引入能够提供快速、准确结果的创新测试方法。分子诊断、血清学测试和核酸扩增技术等先进技术正在被利用，从而提高了灵敏度和特异性。虫媒病毒爆发较多的地区，特别是亚太地区、拉丁美洲和非洲，对虫媒病毒检测解决方案的需求强劲。此外，全球对抗媒介传播疾病（包括虫媒病毒）的努力正在推动医疗机构、研究机构和诊断公司之间的合作，以开发和部署有效的检测策略。随着全球虫媒病毒检测市场的不断发展，产业参与者正专注于产品创新、策略合作伙伴关係以及扩展到新的地理区域，以获得竞争优势。虫媒病毒诊断技术与医疗保健的结合代表着在应对这些传染病带来的挑战方面取得的重大进步，最终有助于加强全球公共卫生。

市场概况
预测期 2025-2029
2023 年市场规模 11.5亿美元
2029 年市场规模 16.1亿美元
2024-2029 年复合年增长率 5.72%
成长最快的细分市场 ELISA 测试
最大的市场 北美洲

主要市场驱动因素

虫媒病毒疾病的发生率上升

提高意识和教育

诊断技术的进步

主要市场挑战

资源有限环境中的可近性有限

公众意识和教育差距

主要市场趋势

加大研发力度

全球监视和监测

细分市场洞察

测试类型见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球虫媒病毒检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依测试类型（RT-PCR 测试、ELISA 测试）
    • 按最终使用者（医院、诊断中心）
    • 按地区
    • 按公司划分 (2023)
  • 市场地图
    • 按测试类型
    • 按最终用户
    • 按地区

第 6 章：亚太地区虫媒病毒检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第 7 章：欧洲虫媒病毒检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 8 章：北美虫媒病毒检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 9 章：南美洲虫媒病毒检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲虫媒病毒检测市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按测试类型
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 埃及

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 13 章：全球虫媒病毒检测市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • Becton Dickinson & Co
  • bioMerieux SA
  • Abbott Laboratories Inc.
  • Quidel Corporation
  • OraSure Technologies, Inc.
  • Hologic Inc. (Gen Probe)
  • Cepheid (Danaher)
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 24013

Global Arbovirus Testing Market was valued at USD 1.15 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 5.72% through 2029. The Global Arbovirus Testing Market has become a vital element in the worldwide healthcare sector due to the increasing threat of arboviruses globally. Arboviruses, primarily transmitted by insects like mosquitoes and ticks, pose a rising concern as they can lead to severe and often fatal human diseases. This market is experiencing notable growth as healthcare systems aim to enhance their diagnostic capabilities for effectively identifying and managing these viral infections. Key drivers for the expansion of the market include the growing incidence of arboviral diseases, heightened awareness among healthcare professionals, and the urgent need for precise and timely diagnostics. Governments and healthcare organizations worldwide are investing in research and development to introduce innovative testing methods that offer rapid and accurate results. Advanced technologies such as molecular diagnostics, serological tests, and nucleic acid amplification techniques are being utilized, providing enhanced sensitivity and specificity. Regions with higher occurrences of arbovirus outbreaks, particularly Asia-Pacific, Latin America, and Africa, are witnessing strong demand for arbovirus testing solutions. Additionally, global efforts to combat vector-borne diseases, including arboviruses, are driving collaborations between healthcare institutions, research bodies, and diagnostic companies to develop and deploy effective testing strategies. As the Global Arbovirus Testing Market continues to progress, industry players are focusing on product innovation, strategic partnerships, and expanding into new geographical areas to gain a competitive advantage. The integration of technology and healthcare in arbovirus diagnostics represents a significant advancement in addressing the challenges posed by these infectious diseases, ultimately contributing to the enhancement of public health worldwide.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 1.15 Billion
Market Size 2029USD 1.61 Billion
CAGR 2024-20295.72%
Fastest Growing SegmentELISA-Test
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Arboviral Diseases

The escalating incidence of arboviral diseases has emerged as a compelling catalyst driving the growth of the Global Arbovirus Testing Market. Arboviruses, transmitted primarily by arthropods like mosquitoes and ticks, pose a significant public health threat globally. The rising prevalence of diseases such as Dengue fever, Zika virus, Chikungunya, and West Nile virus has prompted a critical need for robust diagnostic solutions. As climate change, urbanization, and global travel continue to create favorable conditions for the spread of arboviruses, the frequency and geographic distribution of these diseases are on the rise. This upsurge in cases not only contribute to an increased healthcare burden but also underscores the imperative for timely and accurate diagnostic tools. The demand for arbovirus testing is further intensified by the severity of these infections, which can range from mild symptoms to life-threatening complications. Healthcare systems worldwide are recognizing the urgency of implementing effective testing strategies to identify and manage arboviral diseases promptly. Consequently, the market is witnessing a surge in research and development efforts to enhance diagnostic technologies, including molecular diagnostics and nucleic acid amplification techniques. The synergy between the rising incidence of arboviral diseases and the advancements in testing methodologies underscores the pivotal role of the Global Arbovirus Testing Market in mitigating the impact of these infectious diseases and safeguarding public health on a global scale.

Growing Awareness and Education

The Global Arbovirus Testing Market is experiencing a significant impetus from the growing awareness and education initiatives surrounding arboviral diseases. As the incidence of diseases like Zika virus, Dengue fever, Chikungunya, and West Nile virus continues to rise, there has been a concerted effort to educate healthcare professionals, governments, and the general public about the risks and consequences of these infections. Awareness campaigns, public health programs, and educational outreach activities play a crucial role in disseminating information about the transmission, symptoms, and prevention of arboviruses. This increased awareness has led to a proactive approach toward arbovirus testing, with individuals and healthcare providers recognizing the importance of early detection and timely intervention. Healthcare professionals are equipped with the knowledge to identify symptoms, understand transmission patterns, and implement appropriate testing strategies. Governments and health organizations are actively supporting these educational efforts, contributing to a more informed and vigilant population. This heightened awareness is translating into a growing demand for arbovirus testing solutions, as individuals and healthcare systems recognize the need for accurate and efficient diagnostic tools to manage and control the spread of these infectious diseases. The synergy between growing awareness and the uptake of arbovirus testing underscores the vital role of education in shaping a proactive and responsive approach to combatting arboviral diseases on a global scale.

Advancements in Diagnostic Technologies

Advancements in diagnostic technologies are playing a pivotal role in propelling the Global Arbovirus Testing Market forward. As arboviral diseases pose an increasing global health threat, continuous innovation in diagnostic methodologies is enhancing the precision and efficiency of arbovirus testing. Molecular diagnostics, serological tests, and nucleic acid amplification techniques are at the forefront of these technological advancements. These sophisticated testing methods provide healthcare professionals with highly sensitive and specific tools for the rapid detection and accurate diagnosis of arboviral infections. The utilization of molecular techniques, such as polymerase chain reaction (PCR), enables the identification of viral genetic material, allowing for early and precise detection even in cases with low viral loads. Serological tests, including enzyme-linked immunosorbent assays (ELISA), contribute to the identification of antibodies produced in response to arboviral infections, aiding in both diagnosis and surveillance efforts. Additionally, nucleic acid amplification techniques amplify and detect viral RNA or DNA, enhancing the sensitivity of testing methodologies. The integration of point-of-care testing and portable diagnostic devices further facilitates the timely identification of arboviral infections, especially in resource-limited settings. These technological advancements not only expedite the diagnostic process but also contribute to more efficient and targeted public health interventions. As the Global Arbovirus Testing Market evolves, the continuous progress in diagnostic technologies is expected to drive the market's expansion, enabling healthcare systems to respond more effectively to the challenges posed by arboviral diseases and ultimately improving patient outcomes.

Key Market Challenges

Limited Accessibility in Resource-Limited Settings

Limited accessibility in resource-limited settings stands out as a significant challenge for the Global Arbovirus Testing Market. Regions that are most vulnerable to arboviral diseases often grapple with insufficient healthcare infrastructure, inadequate funding, and a shortage of skilled personnel. These resource constraints hinder the widespread availability and adoption of advanced arbovirus testing solutions. In many instances, remote and underserved areas lack the necessary laboratory facilities and trained personnel to administer and interpret complex diagnostic tests. The absence of basic healthcare amenities in resource-limited settings exacerbates the challenge, hindering the prompt identification and management of arboviral infections. Access to cutting-edge diagnostic technologies, such as molecular tests and nucleic acid amplification techniques, is often limited in these areas, leading to delayed or inaccurate diagnoses. The logistical challenges associated with transporting samples to centralized testing facilities further contribute to the difficulties faced by healthcare systems in such settings. Efforts to address limited accessibility in resource-limited settings require a multi-faceted approach. This includes the development of point-of-care testing devices that are portable, user-friendly, and do not require sophisticated infrastructure. These devices can empower healthcare workers in remote areas to conduct rapid and on-site arbovirus testing, facilitating timely intervention and reducing the burden on centralized laboratories. Collaborative initiatives involving governments, non-governmental organizations, and international bodies are crucial to overcoming the barriers posed by limited resources. Funding and support for capacity-building programs, training healthcare personnel, and establishing sustainable healthcare infrastructures can contribute to enhancing accessibility to arbovirus testing in resource-limited settings. Ultimately, addressing these challenges is essential to ensuring that the benefits of advanced arbovirus testing are extended to populations in need, irrespective of their geographical or economic circumstances.

Public Awareness and Education Gaps

Public awareness and education gaps constitute a significant challenge for the Global Arbovirus Testing Market. Despite the increasing prevalence of arboviral diseases worldwide, there remains a substantial lack of awareness among the general public regarding the risks, symptoms, and preventive measures associated with these infections. Inadequate understanding of arboviruses and their potential impact on public health leads to a delay in seeking medical attention and contributes to the underutilization of arbovirus testing services. Education gaps are not limited to the general public but also extend to healthcare professionals. Misdiagnosis and delayed testing may occur due to insufficient knowledge about the nuances of arboviral diseases, leading to the potential for unchecked transmission and increased morbidity. Addressing these knowledge gaps is crucial to ensure the effective implementation of arbovirus testing strategies. Improving public awareness requires targeted and comprehensive educational campaigns. Governments, healthcare organizations, and advocacy groups play a pivotal role in disseminating information about arboviral diseases, transmission patterns, and the significance of early detection. These campaigns should emphasize the availability and importance of arbovirus testing in preventing the spread of infections and mitigating their impact on individuals and communities. Additionally, healthcare professionals need continuous education and training to stay abreast of the latest developments in arbovirus diagnostics. Collaborative efforts between public health agencies, academic institutions, and medical associations can help bridge the education gaps, ensuring that healthcare providers are well-equipped to recommend and administer appropriate arbovirus testing. Ultimately, addressing public awareness and education gaps is integral to unlocking the full potential of the Global Arbovirus Testing Market. A well-informed public and healthcare workforce will be more proactive in seeking and providing testing services, contributing to early detection, efficient management of arboviral diseases, and the overall improvement of public health outcomes on a global scale.

Key Market Trends

Increased Research and Development

Increased Research and Development (R&D) activities have emerged as a critical driver in advancing the Global Arbovirus Testing Market. The rising incidence of arboviral diseases and the evolving nature of these viruses have propelled the need for more accurate, sensitive, and rapid diagnostic solutions. Research and development efforts within the arbovirus testing sector focus on enhancing existing technologies and innovating new methodologies to meet the growing demands of healthcare systems globally. One notable trend in R&D is the exploration and refinement of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleic acid amplification. These techniques enable the detection of viral genetic material with high sensitivity, providing a valuable tool for early and precise identification of arboviral infections. Additionally, there is a concerted effort to develop point-of-care testing devices that are portable, user-friendly, and suitable for use in resource-limited settings. Such devices empower healthcare professionals to conduct rapid on-site testing, facilitating timely intervention and containment of outbreaks. Collaborations between research institutions, diagnostic companies, and government agencies have played a pivotal role in fostering innovation. These partnerships leverage combined expertise and resources to accelerate the development of cutting-edge testing methodologies. Furthermore, increased funding for arbovirus-related research initiatives has allowed for a more comprehensive understanding of these viruses and the identification of potential therapeutic targets. The integration of artificial intelligence (AI) and machine learning in arbovirus testing is another facet of R&D gaining prominence. These technologies aid in data analysis, interpretation, and prediction, contributing to improved diagnostic accuracy and efficiency. As the Global Arbovirus Testing Market continues to evolve, the commitment to ongoing research and development activities remains crucial. Advancements in technology and diagnostic capabilities resulting from these efforts are pivotal in the global fight against arboviral diseases, enabling healthcare systems to better understand, detect, and manage these infectious threats.

Global Surveillance and Monitoring

Global surveillance and monitoring initiatives are pivotal in shaping the trajectory of the Global Arbovirus Testing Market. The persistent threat of arboviral diseases, including Zika virus, Dengue fever, Chikungunya, and West Nile virus, has led to intensified efforts to establish comprehensive surveillance systems worldwide. Governments, public health organizations, and research institutions are making substantial investments in monitoring arbovirus spread and prevalence to detect outbreaks early and implement timely interventions.

A crucial aspect of global surveillance is establishing robust reporting systems for arboviral infections. Timely and accurate data collection enables the identification of trends, hotspots, and potential areas of concern. These surveillance systems integrate epidemiological data, laboratory results, and environmental factors to provide a holistic view of arbovirus activity. Advanced technologies such as geographic information systems (GIS) and remote sensing have significantly enhanced global surveillance capabilities. These tools facilitate mapping and tracking of arbovirus transmission patterns, aiding authorities in anticipating and responding to potential outbreaks. Real-time data sharing and collaboration between countries and international health organizations contribute to a collective and coordinated global response.

The information gathered through surveillance efforts plays a crucial role in shaping arbovirus testing strategies. It informs resource allocation, deployment of testing facilities, and development of targeted testing protocols. Insights from global monitoring also drive continuous improvement of diagnostic tools and methodologies, ensuring their effectiveness across diverse geographical and epidemiological contexts. As the Global Arbovirus Testing Market evolves, the synergy between surveillance, monitoring, and testing becomes increasingly evident. These interconnected efforts foster a proactive approach to arboviral disease management, aiming to minimize the impact of outbreaks and protect public health worldwide. Collaboration and information-sharing facilitated by global surveillance mechanisms significantly enhance the overall effectiveness of arbovirus testing strategies.

Segmental Insights

Test Type Insights

Based on test type, ELISA tests segment dominated the Global Arbovirus Testing Market in 2023. This is ascribed due to its high sensitivity, specificity, and efficiency in detecting arboviral infections. Enzyme-Linked Immunosorbent Assay (ELISA) tests provide a reliable and cost-effective method for identifying antibodies or antigens associated with arboviruses. ELISA's ability to detect a diverse range of arboviruses and its widespread adoption in diagnostic laboratories contribute to its market dominance. Moreover, ELISA's scalability and suitability for large-scale screening during outbreaks enhance its appeal for arbovirus testing, solidifying its position as a preferred and effective diagnostic tool in the global market.

Regional Insights

North America holds the largest share in the Global Arbovirus Testing Market due to robust healthcare infrastructure, advanced diagnostic technologies, and high awareness levels. The region faces significant arbovirus threats, such as West Nile virus and Zika virus, prompting extensive testing initiatives. Well-established research facilities and collaborations between government agencies and private sectors contribute to cutting-edge testing capabilities. Additionally, proactive public health measures and stringent regulatory frameworks enhance testing protocols. The prevalence of competent vectors and periodic outbreaks further underscores the need for comprehensive arbovirus testing in North America, consolidating its leadership position in addressing and managing arbovirus-related public health challenges.

Key Market Players

Becton Dickinson & Co

bioMerieux SA

Abbott Laboratories Inc.

Quidel Corporation

OraSure Technologies, Inc.

Hologic Inc. (Gen Probe)

Cepheid (Danaher)

QIAGEN N. V.

F. Hoffmann-La Roche Ltd.

Bio-Rad Laboratories, Inc.

Report Scope:

In this report, the Global Arbovirus Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Arbovirus Testing Market, By Test Type:

    RT-PCR Test ELISA-Test

Arbovirus Testing Market, By End User:

    Hospitals Diagnostic Centers

Arbovirus Testing Market, By Region:

    North America

United States

Canada

Mexico

    Europe

France

United Kingdom

Italy

Germany

Spain

    Asia-Pacific

China

India

Japan

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Arbovirus Testing Market.

Available Customizations:

Global Arbovirus Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Arbovirus Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (RT-PCR Test, ELISA-Test)
    • 5.2.2. By End User (Hospitals, Diagnostic Centers)
    • 5.2.3. By Region
    • 5.2.4. By Company (2023)
  • 5.3. Market Map
    • 5.3.1. By Test Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. Asia Pacific Arbovirus Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. Asia Pacific: Country Analysis
    • 6.3.1. China Arbovirus Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By End User
    • 6.3.2. India Arbovirus Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Australia Arbovirus Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By End User
    • 6.3.4. Japan Arbovirus Testing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Test Type
        • 6.3.4.2.2. By End User
    • 6.3.5. South Korea Arbovirus Testing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Test Type
        • 6.3.5.2.2. By End User

7. Europe Arbovirus Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Arbovirus Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Arbovirus Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By End User
    • 7.3.3. Spain Arbovirus Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Arbovirus Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By End User
    • 7.3.5. United Kingdom Arbovirus Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By End User

8. North America Arbovirus Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Arbovirus Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By End User
    • 8.3.2. Mexico Arbovirus Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Canada Arbovirus Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By End User

9. South America Arbovirus Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Arbovirus Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Arbovirus Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Arbovirus Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Arbovirus Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Arbovirus Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Arbovirus Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Arbovirus Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By End User
    • 10.3.4. Egypt Arbovirus Testing Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Test Type
        • 10.3.4.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Arbovirus Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Becton Dickinson & Co
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (In case of listed)
    • 15.1.5. Recent Developments
    • 15.1.6. SWOT Analysis
  • 15.2. bioMerieux SA
  • 15.3. Abbott Laboratories Inc.
  • 15.4. Quidel Corporation
  • 15.5. OraSure Technologies, Inc.
  • 15.6. Hologic Inc. (Gen Probe)
  • 15.7. Cepheid (Danaher)
  • 15.8. QIAGEN N. V.
  • 15.9. F. Hoffmann-La Roche Ltd.
  • 15.10. Bio-Rad Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer